Laser-Ignited Lipid Peroxidation Nanoamplifiers for Strengthening Tumor Photodynamic Therapy Through Aggravating Ferroptotic Propagation and Sustainable High Immunogenicity

Yunong Ma,Xi Zhao,Peilin Tian,Kexin Xu,Jiayang Luo,Honghui Li,Mingqing Yuan,Xu Liu,Yanping Zhong,Pingzhen Wei,Jiaxing Song,Liewei Wen,Cuixia Lu

DOI: https://doi.org/10.1002/smll.202306402

IF: 13.3

2024-01-01

Small

Abstract:Photodynamic therapy (PDT) is extensively investigated for tumor therapy in the clinic. However, the efficacy of PDT is severely limited by the tissue penetrability of light, short effective half-life and radius of reactive oxygen species (ROS), and the weak immunostimulatory effect. In this study, a glutathione (GSH)-activatable nano-photosensitizer is developed to load with arachidonic acid (AA) and camouflage by erythrocyte membrane, which serves as a laser-ignited lipid peroxidation nanoamplifier (MAR). The photosensitive effect of MAR is recovered accompanied by the degradation in the tumor microenvironment and triggers the peroxidation of AA upon laser excitation. Interestingly, it aggravates the propagation of ferroptosis among cancer cells by driving the continuous lipid peroxidation chain reactions with the participation of the degradation products, ferrous ions (Fe2+), and AA. Consequently, even the deep-seated tumor cells without illumination also undergo ferroptosis owing to the propagation of ferroptotic signal. Moreover, the residual tumor cells undergoing ferroptosis still maintain high immunogenicity after PDT, thus continuously triggering sufficient tumor-associated antigens (TAAs) release to remarkably promote the anti-tumor immune response. Therefore, this study will provide a novel "all-in-one" nano-photosensitizer that not only amplifies the damaging effect and expands the effective range of PDT but also improves the immunostimulatory effect after PDT. A GSH-activatable nano-photosensitizer is developed to load with arachidonic acid, which serves as laser-ignited lipid peroxidation nano-amplifiers. It is able to aggravate the propagation of ferroptosis among cancer cells through driving the continuous lipid peroxidation chain reactions, which will potentiate the PDT. Particularly, the residual tumor cells undergoing ferroptosis still maintain high immunogenicity, thus continuously promote the anti-tumor immune response.image